Carnegie Pharmaceuticals LLC

Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees

Carnegie Pharmaceuticals LLC is a pharmaceutical manufacturer based in Delran, New Jersey, that focuses on developing and producing specialized generic and branded medicines with development barriers. It has invested in its team, facilities, and pipeline to deliver United States-made medicines for both domestic and global distribution, positioning itself in the niche of complex pharmaceutical formulations.

Its commercial offerings include primidone tablets and several erythromycin-based products such as E.E.S. granules, E.E.S. 400 tablets, and EryPed 400, along with other therapies like clindamycin phosphate pledgets, balsalazide disodium capsules, aminocaproic acid oral suspension, famotidine for oral suspension, and lomustine capsules. In October 2025, Carnegie Pharmaceuticals announced a collaboration with Biocon Biologics Limited (Biocon Pharma Ltd.), indicating a strategic partnership related to its medication portfolio. The company operates with a small to mid-sized team and pursues both domestic and global distribution opportunities in the pharmaceutical manufacturing sector.

Sign up for free to view info

Email Format Employee directory